Filtered By:
Condition: Depression
Countries: China Health

This page shows you your search results in order of date. This is page number 11.

Order by Relevance | Date

Total 1020 results found since Jan 2013.

Prospective association between depressive symptoms and stroke risk among middle-aged and older Chinese
This study aimed to assess the association between baseline symptoms and changes in depressive symptoms and stroke incidents.
Source: BMC Psychiatry - October 27, 2021 Category: Psychiatry Authors: Yimin Cui, Chunsu Zhu, Zhiwei Lian, Xueyan Han, Qian Xiang, Zhenming Liu and Ying Zhou Tags: Research article Source Type: research

Jidong Restless Legs Syndrome Cohort Study: Objectives, Design, and Baseline Screening
This study will contribute to the scientific evidence on the association between RLS and cardiovascular risks and also provide an unprecedented opportunity for early detection and prevention of CVD.
Source: Frontiers in Neurology - October 13, 2021 Category: Neurology Source Type: research

Morinda officinalis oligosaccharides alleviate depressive-like behaviors in post-stroke rats via suppressing NLRP3 inflammasome to inhibit hippocampal inflammation
CONCLUSION: Overall, our study reveals the antidepressive effect of MOOs on PSD rats through modulation of microglial NLRP3 inflammasome. We also provide a novel insight into hippocampal inflammation response in PSD pathology and put forward NLRP3 inflammasome as a potential therapeutic target for PSD.PMID:34559953 | DOI:10.1111/cns.13732
Source: CNS Neuroscience and Therapeutics - September 24, 2021 Category: Neuroscience Authors: Zhifang Li Hexiang Xu Yi Xu Guanfeng Lu Qiwei Peng Jiefang Chen Rentang Bi Jianzhuang Li Shengcai Chen Hongkai Li Huijuan Jin Bo Hu Source Type: research

Efficacy and Tolerability of Selective Serotonin Reuptake Inhibitors on Promoting Motor Recovery After Stroke:Meta-Analysis of Randomized Controlled Trials
CONCLUSIONS: SSRIs are effective and well-tolerated to promote motor recovery after stroke, but may increase the risk of seizures and gastrointestinal adverse effects.PMID:34538154 | DOI:10.1080/14737175.2021.1982696
Source: Expert Review of Neurotherapeutics - September 20, 2021 Category: Neurology Authors: Dongyun Su Yuqing Zhang Anzi Wang Di Shao Fenghua Xu Meng Dong Libo Zhao Yang Hu Haiyan Luo Source Type: research